1. Home
  2. CVE Database
  3. CVE-2022-48221
HIGH · 7.5

CVE-2022-48221

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files c...

Vulnerability Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).

CVSS Score

7.5

HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
NETWORK
Attack Complexity
HIGH
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
GbgplcAcuant Acufill Sdk< 10.22.02.03

Related Weaknesses (CWE)

CWE-362

References

FAQ

What is CVE-2022-48221?

CVE-2022-48221 is a vulnerability with a CVSS score of 7.5 (HIGH). An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files c...

How severe is CVE-2022-48221?

CVE-2022-48221 has been rated HIGH with a CVSS base score of 7.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-48221?

Check the references section above for vendor advisories and patch information. Affected products include: Gbgplc Acuant Acufill Sdk.